Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (301-310 of 414) with videos related to

Pageof 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research HospitalA W Walter, M L Hancock, C H Pui, et al.
Cancer|May 15, 1993
Progress in the treatment of adolescents with acute lymphoblastic leukemiaG K Rivera, C H Pui, V M Santana, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.
Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.
Medical and Pediatric Oncology|January 1, 1986
Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemiaG K Rivera, S L George, D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemiaG K Rivera, W E Evans, D K Kalwinsky, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Leukemia|April 14, 2000
Prognostic factors in infants with acute myeloid leukemiaC H Pui, S C Raimondi, D K Srivastava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.
Pageof 42

Showing results (301-310 of 414) with videos related to

Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research HospitalA W Walter, M L Hancock, C H Pui, et al.
Cancer|May 15, 1993
Progress in the treatment of adolescents with acute lymphoblastic leukemiaG K Rivera, C H Pui, V M Santana, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.
Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.
Medical and Pediatric Oncology|January 1, 1986
Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemiaG K Rivera, S L George, D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemiaG K Rivera, W E Evans, D K Kalwinsky, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Leukemia|April 14, 2000
Prognostic factors in infants with acute myeloid leukemiaC H Pui, S C Raimondi, D K Srivastava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.
Pageof 42